Techasaensiri, C.; Wongsa, A.; Puthanakit, T.; Chokephaibulkit, K.; Chotpitayasunondh, T.; Charoonruangrit, U.; Sombatnimitsakul, S.; Puthavathana, P.; Lerdsamran, H.; Auewarakul, P.;
et al. Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study. Pathogens 2021, 10, 625.
https://doi.org/10.3390/pathogens10050625
AMA Style
Techasaensiri C, Wongsa A, Puthanakit T, Chokephaibulkit K, Chotpitayasunondh T, Charoonruangrit U, Sombatnimitsakul S, Puthavathana P, Lerdsamran H, Auewarakul P,
et al. Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study. Pathogens. 2021; 10(5):625.
https://doi.org/10.3390/pathogens10050625
Chicago/Turabian Style
Techasaensiri, Chonnamet, Artit Wongsa, Thanyawee Puthanakit, Kulkanya Chokephaibulkit, Tawee Chotpitayasunondh, Ubonwon Charoonruangrit, Somjai Sombatnimitsakul, Pilaipan Puthavathana, Hatairat Lerdsamran, Prasert Auewarakul,
and et al. 2021. "Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study" Pathogens 10, no. 5: 625.
https://doi.org/10.3390/pathogens10050625
APA Style
Techasaensiri, C., Wongsa, A., Puthanakit, T., Chokephaibulkit, K., Chotpitayasunondh, T., Charoonruangrit, U., Sombatnimitsakul, S., Puthavathana, P., Lerdsamran, H., Auewarakul, P., & Tassaneetrithep, B.
(2021). Response of Severe EV71-Infected Patients to Hyperimmune Plasma Treatment: A Pilot Study. Pathogens, 10(5), 625.
https://doi.org/10.3390/pathogens10050625
